Evaluation of the Association Between CYP2D6 Genetic Polymorphisms and the Treatment Effect of Tamoxifen

NCT00532454 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

21

Enrollment

OTHER_GOV

Sponsor class

Stopped planned to design a prospective study

Conditions

Breast Cancer
Metastatic Disease

Interventions

DRUG: Tamoxifen

Sponsor

National Cancer Center, Korea